Gabriela Rosa is a student in Harvard Chan School’s Doctor of Public Health Program and the new president of the Harvard Chan Student Association. She’s also a fertility expert, a watercolor painter, and a weightlifter.
Roughly 150 Harvard Chan School alumni gathered in late September for reconnecting, networking, and learning at the annual Alumni Weekend. The focus of the event was “The Right to Health: Equity and Justice for All.”
Hair products sold in neighborhoods that are poorer or that have a higher percentage of residents of color were more likely to contain higher levels of hazardous chemicals than products sold in predominantly white and affluent areas, according…
A new podcast delves into what women can do to improve their health and wellbeing to boost their fertility, focusing on topics such as toxins in the home, diet, exercise, sex and intimacy, and mental health.
Amid a recent wave of policies targeting LGBTQ populations across the U.S., a Harvard collaborative focused on LGBTQ health is doubling down on its work.
Through predictive models, it may be possible to identify pregnant women in low-resource settings who are at high risk of failing to attend antenatal care, in order to develop interventions to encourage their attendance, according to a new…
Early life trauma is an important and overlooked cause of adverse reproductive health outcomes in women such as endometriosis, premenstrual dysphoric disorder (PMDD), and infertility, according to a recent investigation from researchers at Harvard Chan School.
Zachary Ward, research scientist in the Center for Health Decision Science, explains his recent pair of studies predicting trends in global maternal mortality and evaluating the effectiveness of interventions to curb maternal deaths.
Communities of color, notably Black people, are disproportionately exposed to harmful chemicals via personal care items such as hair products, studies have found. Harvard Chan School doctoral student Marissa Chan thinks it’s important to change the societal factors…
During pregnancy, the timing of when mothers start taking antiretroviral drugs to treat HIV may impact the risk of developmental delays in children, according to a study co-authored by researchers at Harvard Chan School.